Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.

Literature DB >> 12041851

Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.

Eric Wooltorton.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12041851 PMCID： PMC111085

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

8 in total

Review 1. Obesity.

Authors: Susan Z Yanovski; Jack A Yanovski
Journal: N Engl J Med Date: 2002-02-21 Impact factor: 91.245

2. A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity.

Authors: G Fanghänel; L Cortinas; L Sánchez-Reyes; A Berber
Journal: Int J Obes Relat Metab Disord Date: 2000-02

3. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

Authors: F G McMahon; K Fujioka; B N Singh; C M Mendel; E Rowe; K Rolston; F Johnson; A D Mooradian
Journal: Arch Intern Med Date: 2000-07-24

4. Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

Authors: D S Bach; A M Rissanen; C M Mendel; G Shepherd; S P Weinstein; F Kelly; T B Seaton; B Patel; T A Pekkarinen; W F Armstrong
Journal: Obes Res Date: 1999-07

5. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors: W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal: Lancet Date: 2000 Dec 23-30 Impact factor: 79.321

6. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Authors: K Fujioka; T B Seaton; E Rowe; C A Jelinek; P Raskin; H E Lebovitz; S P Weinstein
Journal: Diabetes Obes Metab Date: 2000-06 Impact factor: 6.577

7. Long-term weight loss with sibutramine: a randomized controlled trial.

Authors: A Wirth; J Krause
Journal: JAMA Date: 2001-09-19 Impact factor: 56.272

Review 8. Sibutramine and energy balance.

Authors: A Astrup; D L Hansen; C Lundsgaard; S Toubro
Journal: Int J Obes Relat Metab Disord Date: 1998-08

8 in total

14 in total

1. Over-the-Counter Herbal Weight Loss Supplements in Egypt: Label Claim, Microbiological and Pharmaceutical Quality, and Safety Assessments.

Authors: Nada Ahmed; Mohamed Ismail Nounou; Alaa Abouelfetouh; Amal El-Kamel
Journal: Med Princ Pract Date: 2018-12-05 Impact factor: 1.927

Review 2. Safety of drug therapies used for weight loss and treatment of obesity.

Authors: Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal: Drug Saf Date: 2006 Impact factor: 5.606

Review 3. Pharmacotherapy for obesity.

Authors: Lisa L Ioannides-Demos; Joseph Proietto; John J McNeil
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 10. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Authors: Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal: BMC Med Date: 2016-11-29 Impact factor: 8.775

Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.

Review 1. Obesity.

2. A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity.

3. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

4. Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

5. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

6. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

7. Long-term weight loss with sibutramine: a randomized controlled trial.

Review 8. Sibutramine and energy balance.

1. Over-the-Counter Herbal Weight Loss Supplements in Egypt: Label Claim, Microbiological and Pharmaceutical Quality, and Safety Assessments.

Review 2. Safety of drug therapies used for weight loss and treatment of obesity.

Review 3. Pharmacotherapy for obesity.

Review 4. Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Review 5. Long-term pharmacotherapy for obesity and overweight.

6. QT interval prolongation associated with sibutramine treatment.

Review 7. Sibutramine on cardiovascular outcome.

Review 8. The use of serotonergic drugs to treat obesity--is there any hope?

9. Anti-hyperlipidemic effect of soybean extract fermented by Bacillus subtilis MORI in db/db mice.

Review 10. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.